JPMorgan upgrades Sociedad Quimica y Minera stock rating on valuation

JPMorgan upgraded SQM to Overweight from Neutral but cut its price target to $71 from $88 and lowered 2026/2027 EBITDA estimates to $4.0B/$3.3B, citing lithium-price assumptions 38% below its prior assumptions; its 2027 estimate is 16% below consensus. The firm forecasts lithium deficits in 2026–27 and prices reaching $17,000 per ton by year-end 2027, 42% above current spot. Separately, SQM reported Q2 2026 EPS of $2.31 and revenue of $2.47B, beating estimates of $1.91 and $2.19B; shares are reported down 39% over six months.

Analysis

The signal is more constructive on SQM’s relative valuation and execution than on near-term earnings: JPMorgan raised its rating while cutting its EBITDA path materially. That distinction matters—an equity rerating can occur before earnings inflect, but the case remains exposed to lithium-price assumptions rather than a clean estimate-revision cycle. Treat the projected 2026–27 deficits as a scenario, not established scarcity; supply restarts and expansions, especially if prices improve, can cap the recovery. Battery-storage demand is an incremental support, but chemistry substitution and lower lithium intensity are relevant offsets over a 6–18 month horizon.

SQM’s reported volume strength can cushion weaker pricing, but investors should verify realized lithium prices, unit costs, and cash conversion: volume growth does not guarantee EBITDA growth if price declines outrun cost reductions. The competing broker optimism and the lower JPMorgan target also make headline ratings a poor standalone catalyst. For Sigma Lithium, the relative-preference comment is not enough to justify a short without comparable valuation, project execution, and liquidity data.

Near term, expect estimates and lithium spot prices to matter more than the rating change. Over 1–3 months, watch contract-price resets and quarterly realized prices; over 6–18 months, the key test is whether storage demand absorbs incremental supply without a price-led supply response. A staged SQM long is reasonable only for investors seeking cyclical exposure with tolerance for drawdowns. The thesis weakens if lithium prices fail to stabilize, SQM’s realized prices or unit costs disappoint, or guidance cuts persist despite volume growth.

Key Decisions for Investors

• Consider a staged, modest SQM long rather than chasing the rating headline; add only if subsequent disclosures confirm stable realized pricing and cost performance. The upside case depends on a lithium-price recovery, while estimate revisions remain a near-term downside risk.
• Track lithium spot and contract prices alongside SQM’s realized prices, unit costs, and operating cash flow at the next results. Strong volumes without improving price realization or cash conversion would falsify the operating-leverage thesis.
• Keep the 2026–27 deficit forecast as a catalyst watch, not a base-case fact. Reassess if new supply plans accelerate or storage-demand growth fails to translate into lithium consumption.
• Do not short SGML solely on JPMorgan’s stated preference for SQM; first compare current valuation, execution milestones, and funding/liquidity data.